LexBlog IP

MARCH 6, 2024

Under the agreement, Biocon can launch YESAFILI in Canada no later than July 1, 2025. The post Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar appeared first on Big Molecule Watch. The settlement resolves multiple patent infringement proceedings in the Federal Court of Canada.

Marketing 52

Marketing Marketing Settlement Litigation 52

The IPKat

FEBRUARY 4, 2022

The EU Toolbox is part of the EU Strategy to tackle Organised Crime 2021-2025. The EC reports that despite efforts to battle counterfeit goods, the market is still thriving, with an increase of detained articles at EU borders.

Due Diligence 131

Due Diligence IP Technology Licensing 131

Velocity of Content

AUGUST 5, 2024

Armstrong concluded her speech by expressing her excitement about the 2025 IFRRO Asia Pacific Committee (APC) meeting, which will be hosted by IRRO in New Dellhi. Licensing solutions such as direct and collective licensing meet the needs of technology companies, users of copyrighted works, authors and publishers.”

Publishing 98

Publishing Licensing Technology Copyright 98

LexBlog IP

MAY 19, 2023

billion by 2025, at a compound annual growth rate of 32%. Influencer marketing offers brands a unique opportunity to target and connect with online communities, using a personalized approach. Potential parties could be, a marketing agency, talent management or PR firms, the individual influencer, or the brand.

Marketing 52

Marketing Marketing Contracts Branding 52

JD Supra Law

AUGUST 31, 2023

market on March 7, 2025, if approved by FDA. It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. By: Goodwin

Settlement 74

Settlement Reporting Marketing Marketing 74

The IPKat

OCTOBER 28, 2024

The hybrid event, taking place on 28 and 29 January 2025, will address the latest developments and challenges in geographical indications for craft and agricultural products. Papers in French or English covering any topic related to IP law may be submitted no later than 21 February 2025. More information here. Review the report here.

Intellectual Property 67

Intellectual Property Editing IP Publishing 67

LexBlog IP

MARCH 6, 2024

The agreement allows Biocon to launch in the United States in February 2025, pending FDA approval. entry date for its ustekinumab biosimilar, WEZLANA, of January 1, 2025, and in October 2023, the FDA approved WEZLANA as biosimilar to and interchangeable with STELARA. Amgen secured a U.S.

Marketing 40

Marketing Marketing Settlement Licensing 40

Bio Law Blog

JUNE 21, 2020

settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. and Alexion Pharmaceuticals Inc. an eculizumab product.

Marketing 52

Marketing Marketing Settlement Patent 52

LexBlog IP

DECEMBER 13, 2023

Samsung Bioepis recently reported that it has signed a settlement and license agreement with Johnson & Johnson (“J&J”) in the United States relating to SB17, Samsung Bioepis’s ustekinumab biosimilar to J&J’s STELARA® If SB17 is approved by the FDA, the license period in the United States will begin on February (..)

Litigation 52

Litigation Settlement Licensing Marketing 52

LexBlog IP

JUNE 13, 2023

. “According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025.” The post Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J appeared first on Big Molecule Watch.

Settlement 52

Settlement Marketing Marketing Licensing 52

IP Law 360

NOVEMBER 7, 2024

With a number of major reforms to the European Union's design protection system set to take effect in the first half of 2025, U.S. companies need to stay informed about specific details to maintain effective intellectual property management in the EU market, say lawyers at Finnegan.

Intellectual Property Management 52

Intellectual Property Management Designs Design Intellectual Property 52

The IPKat

NOVEMBER 25, 2024

10th OxFirst IP and Competition Forum (13 January 2025) OxFirst, an Oxford-based IP law and economics consultancy is hosting the 10th Intellectual Property and Competition Forum at the University of Oxford on Saturday, January 13th, 2024. For further information and to register click here. To register, click here.

Intellectual Property 62

Intellectual Property Editing Intellectual Property Law IP 62

Indiana Intellectual Property Law

NOVEMBER 12, 2024

Novartis is a Swiss pharmaceutical company known for developing innovative medicines and therapies, particularly in the radiopharmaceutical market. The company is taking steps to strengthen its position by filing lawsuits against competitors over alleged patent violations concerning its top cancer therapies, Pluvicto and Lutathera.

Patent 52

Patent Marketing Marketing Designs 52

The IPKat

AUGUST 13, 2024

Topics to be covered include: how will the EU IP Action Plan impact the Single Market? AlgoSoc International Conference 2025: 10 April 2025. 2025 Annual Meeting, 17 May 2025, San Diego, California, USA. What is the future of IP in the context of Artificial Intelligence? Call for abstracts. Details here.

Intellectual Property 62

Intellectual Property IP Journalism Confidentiality 62

LexBlog IP

AUGUST 16, 2023

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.

Settlement 52

Settlement Licensing Confidentiality Marketing 52

TorrentFreak

DECEMBER 17, 2023

Running for four seasons from the 2025-26 campaign, the deal will see broadcasters Sky and TNT take the live games and the BBC continue with its popular highlights package. Early December the English Premier League announced a new broadcasting rights deal worth a staggering £6.7 billion (US$8.5

Licensing 124

Licensing Copyright Marketing Marketing 124

Herbert Smith Freehills

OCTOBER 14, 2021

The global oncology drug market was valued at US$150.3 billion in 2025 at a CAGR of 15.2%, and to grow further to US$482.5 from 2025 to 2030. Precision oncology and immuno-oncology therapies in which Abbisko specialises are expected to account for approximately 90% of the global oncology drug market by 2030. HK?????????06609.HK????????06669.HK??.

Marketing 52

Marketing Marketing Licensing Publishing 52

TorrentFreak

AUGUST 7, 2023

The injunction allows the Premier League to block pirate IPTV services during the 2023/24 season and then the 2024/2025 season after that. Genip.tv, which is linked to geniptv.com, appeared in the MPA’s submission to the USTR’s Notorious Markets report 2021.

Branding 98

Branding Brands Branding Public Domain 98

TorrentFreak

DECEMBER 6, 2023

EU’s Geo-Blocking Restrictions To counter consumer-unfriendly limitations, the European Commission previously banned certain types of geo-blocking as part of the Digital Single Market reforms. The report recommends the EU Commission to launch a comprehensive review of the current geo-blocking regulation and have that completed by 2025.

Licensing 121

Licensing Reporting Cinema Marketing 121

LexBlog IP

JANUARY 12, 2023

Coherus plans to file an abbreviated Biologics License Application (aBLA) with the FDA later this year and intends to launch the product at EYLEA biosimilar market formation, currently expected to be in 2025.

Marketing 52

Marketing Marketing Licensing Intellectual Property 52

Herbert Smith Freehills

JANUARY 13, 2022

In 2020, JL Mag ranked first in the world by high-performance REPM production volume with a market share of approximately 14.5%. tonnes in 2025 at a CAGR of 14.7%. "We 2025????????12.91???????????14.7%?. The IPO raised over HK$4.045 billion (approximately US$520 million), and listed on 14 January 2022. tonnes in 2015 to 65,000.0

Marketing 52

Marketing Marketing Publishing Law 52

The IPKat

FEBRUARY 29, 2024

Under the new GI Regulation, GIs for wines, spirit drinks and agricultural products may all be cancelled if no product has been placed on the market under the GI for at least the last seven consecutive years. It will be applicable as of 1 January 2025. Other aspects This Kat also notes two additional aspects of the new GI Regulation.

Art 109

Art Registration Journalism Intellectual Property 109

Herbert Smith Freehills

NOVEMBER 7, 2021

Leading global law firm Herbert Smith Freehills has advised CMBC Securities Company Limited and Guotai Junan Securities (Hong Kong) Limited as joint global coordinators of online marketing solutions provider UJU Holding Limited (01948.HK)'s The online short video marketing market in China increased from RMB30.2 2025????????7043???????????30.7%?.

Advertising 52

Advertising Advertising Marketing Marketing 52

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 52

IP Marketing Marketing Licensing 52

Olartemoure Blog

MAY 24, 2024

In addition to what was previously reported, this new law includes a sanctioning regime for those producers or marketers who fail to comply with it, as follows: Fines between USD 85,055 to USD 102,066 for non-compliance with labeling obligations and warning seals on packaging.

Advertising 52

Advertising Advertising Intellectual Property Reporting 52

LexBlog IP

AUGUST 30, 2023

market on March 7, 2025, if approved by FDA. It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S.

Settlement 40

Settlement Confidentiality Marketing Marketing 40

The IPKat

OCTOBER 1, 2024

People, Plants, and the Law lecture series This online lecture series returns for another year to explore the special role of the law in shaping how people engage with plants, whether in farmers’ fields, scientific laboratories, international markets, or elsewhere. Registration will open in January.

Editing 57

Editing Registration Law Copyright Law 57

Herbert Smith Freehills

DECEMBER 13, 2021

HK), online marketing solutions provider Netjoy Holdings Limited (02131.HK), HK), and online marketing solutions provider UJU Holding Limited (01948.HK). Our proven expertise in advising clients from internet and related sectors adds to our three-decade local capital market capability. "Our billion in 2025 at a CAGR of 40.1%.

Marketing 52

Marketing Marketing Business Technology 52

Technology & Marketing Law Blog

APRIL 28, 2023

If passed, the bill goes into effect July 1, 2024 with the first round of DPIAs due July 1, 2025. Recently, the Senate Judiciary Committee heard the bill for informational purposes. The bill is currently pending approval by both chambers. Enforcement is limited to the MN AG.

Copying 133

Copying Designs Design Blogging 133

The IPKat

NOVEMBER 14, 2022

The latter, contrary to what it might appear from its date of adoption (2014), is a regulation that is certainly topical, having started to take effect as of 31 July 2022, with a transitional period that will last until 31 January 2025, but which will see a first and fundamental provision entering into force on 31 January 2023.

IP 76

IP Marketing Marketing Confidentiality 76

The IPKat

OCTOBER 20, 2024

Unsurprisingly, the chapter on wine (Chapter 4) is the longest chapter, which includes additional detail about the regulations for wines in the Common Organisation of Agricultural Markets (CMO) in the new edition. Chapter 5 then considers the protection of spirits and the relevant case law.

Editing 73

Editing Law Intellectual Property Publishing 73

The IPKat

AUGUST 31, 2023

Open-Source: Requiring code to be openly available may promote transparency and innovation; allowing it to be proprietary may concentrate market power but allow more dependable regulation of harms. Black Box: Some AI models and tools cannot explain why they produce a particular result, which is a challenge to transparency requirements.

Reporting 89

Reporting Technology Intellectual Property Government 89

The IPKat

OCTOBER 8, 2024

In a case involving a patent for herbicide compositions, the UPC Munich Local Division was asked to consider whether the alleged infringer's marketing of a product within the Contracting Member States under the same brand name as a clearly infringing product sold outside the Member States created a risk of first (or imminent) infringement.

Advertising 62

Advertising Advertising Patent Infringement Cease and Desist 62

Technology & Marketing Law Blog

FEBRUARY 29, 2024

WIPIP 2025 will be hosted by the UNLV Law School in Las Vegas. * * * As usual, Prof. This juxtaposition leaves me with a bittersweet memory of WIPIP 2024. We had so much fun together, but it also will be associated with Dan’s death and our community’s loss. My memoriam for Dan.

Fair Use 69

Fair Use Intellectual Property IP Law 69

The IPKat

DECEMBER 17, 2024

The consultation is likely to elicit strong views from both sides of the debate; some rightsholders will be dismayed at the potential weakening of their rights in a very important market for creators, whereas AI developers will want to know how any proposals will apply in practice. The consultation runs until 25 February 2025.

Copyright 62

Copyright Government Personality Rights IP 62

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 40

IP Marketing Marketing Licensing 40

SpicyIP

JULY 8, 2024

CGPDTM Announces Dates for 2025 Trademark and Patent Agent Exams Dates for Trademark and Patent Agent Exams 2025 have been announced by the CGPDTM. The Trademark Agent Exam is likely to be held on January 04, 2025 and the Patent Agent Exam is likely to be held on January 5, 2025.

Invention 59

Invention Art Trademark Patent Application 59